Longbow Finance’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.97M Buy
10,843
+3,422
+46% +$3.47M 1.81% 15
2025
Q4
$7.98M Sell
7,421
-5,895
-44% -$5.64M 1.35% 24
2025
Q3
$10.2M Sell
13,316
-5,637
-30% -$4.19M 1% 37
2025
Q2
$14.8M Sell
18,953
-11,721
-38% -$9.11M 1.58% 14
2025
Q1
$25.3M Buy
30,674
+12,421
+68% +$10.3M 3.03% 9
2024
Q4
$14.1M Buy
18,253
+864
+5% +$715K 1.54% 15
2024
Q3
$15.4M Sell
17,389
-6,488
-27% -$5.83M 1.64% 13
2024
Q2
$21.6M Sell
23,877
-1,328
-5% -$1.06M 2.23% 9
2024
Q1
$19.6M Buy
25,205
+10,662
+73% +$7.59M 1.98% 10
2023
Q4
$8.48M Sell
14,543
-2,802
-16% -$1.64M 0.86% 44
2023
Q3
$9.32M Sell
17,345
-59
-0.3% -$30.4K 1.12% 32
2023
Q2
$8.16M Buy
+17,404
New +$7.3M 0.95% 41

Other funds holding LLY

Longbow Finance's LLY Position: Q1 2026 in Review

Longbow Finance increased its Eli Lilly (LLY) stake by 46% in Q1 2026, buying an estimated $3.47M and bringing the position to 10,843 shares worth $9.97M. The position accounts for 1.81% of the portfolio, ranked #15.

Longbow Finance first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $25.3M in Q1 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Longbow Finance held 10,843 shares of Eli Lilly worth $9.97M as of Q1 2026.
  • Longbow Finance bought 3,422 Eli Lilly shares in Q1 2026, an estimated $3.47M.
  • Eli Lilly made up 1.81% of Longbow Finance's portfolio in Q1 2026, its #15 holding.
  • Longbow Finance first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
  • Longbow Finance's Eli Lilly position peaked at $25.3M in Q1 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Longbow Finance's 13F filing for Q1 2026, filed 12 May 2026.